Literature DB >> 33776905

Long Noncoding RNA X-Inactive-Specific Transcript Promotes the Secretion of Inflammatory Cytokines in LPS Stimulated Astrocyte Cell Via Sponging miR-29c-3p and Regulating Nuclear Factor of Activated T cell 5 Expression.

Mengqi Zhang1, Haojun Yang1, Zhuohui Chen1, Xinhang Hu1, Tong Wu1, Weiping Liu1.   

Abstract

Background: Astrocyte activation promotes glutamate accumulation and secretion of inflammatory factors, mainly responsible for epilepsy. Long noncoding RNA (lncRNA) X-inactive-specific transcript (XIST) regulates inflammation; however, the biological role and regulatory mechanism of XIST during astrocyte activation remain unclear.
Methods: In the present study, rat epilepsy model and lipopolysaccharide (LPS)-treated CTX-TNA2 were established. XIST and miR-29c-3p expression were evaluated using quantitative real-time polymerase chain reaction. Nuclear factor of activated T cells 5 (NFAT5) was measured using western blot analysis. Interleukin (IL)-1β, IL-6, tumor necrosis factor-α, and L-glutamate levels in the culture supernatants were assessed using enzyme-linked immunosorbent assay. The binding between XIST and miR-29c-3p and between miR-29c-3p and the 3'-UTR of NFAT5 was analyzed using dual-luciferase reporter, RNA-binding protein immunoprecipitation (RIP), and Biotin pull-down assay. The proliferation and apoptosis were evaluated using CCK8 and flow cytometry, respectively.
Results: XIST expression and NFAT5 protein level was increased, whereas miR-29c-3p expression was decreased in the epilepsy rat model and LPS-treated CTX-TNA2 cells. Silenced XIST expression, miR-29c-3p overexpression, or silenced NFAT5 expression inhibited the secretion of IL-1β, IL-6, and TNF-α and promoted glutamate transport in LPS-treated CTX-TNA2 cells. miR-29c-3p was the potential miRNA sponged by XIST. NFAT5 acted as a direct binding target of miR-29c-3p. Silenced miR-29c-3p expression or NFAT5 overexpression reversed the effect of silenced XIST expression on LPS-treated CTX-TNA2.XIST and miR-29c-3p treatment does not affect NFAT5 mRNA expression, but affects NFAT5 protein level. Furthermore, underexpressed XIST or overexpressed miR-29c-3p in LPS-stimulated CTX-TNA2 can attenuate neuronal apoptosis induced by LPS-stimulated CTX-TNA2.
Conclusion: LncRNA XIST promotes the secretion of inflammatory cytokines in LPS- treated CTX-TNA2 via sponging miR-29c-3p and regulating NFAT5 expression.
Copyright © 2021 Zhang, Yang, Chen, Hu, Wu and Liu.

Entities:  

Keywords:  astrocyte; epilepsy; inflammatory cytokine; lncRNA; microRNA

Mesh:

Substances:

Year:  2021        PMID: 33776905      PMCID: PMC7995889          DOI: 10.3389/fendo.2021.573143

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  43 in total

Review 1.  NFAT5 Has a Job in the Brain.

Authors:  Xing-Liang Yang; Xin Wang; Bi-Wen Peng
Journal:  Dev Neurosci       Date:  2018-11-02       Impact factor: 2.984

2.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

Review 3.  Glia and epilepsy: excitability and inflammation.

Authors:  Orrin Devinsky; Annamaria Vezzani; Souhel Najjar; Nihal C De Lanerolle; Michael A Rogawski
Journal:  Trends Neurosci       Date:  2013-01-05       Impact factor: 13.837

4.  Resveratrol differentially modulates inflammatory responses of microglia and astrocytes.

Authors:  Xiaofeng Lu; Lili Ma; Lingfei Ruan; Yan Kong; Haiwei Mou; Zhijie Zhang; Zhijun Wang; Ji Ming Wang; Yingying Le
Journal:  J Neuroinflammation       Date:  2010-08-17       Impact factor: 8.322

5.  Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release.

Authors:  Emilio Russo; Francesco Andreozzi; Rodolfo Iuliano; Vincenzo Dattilo; Teresa Procopio; Giuseppe Fiume; Selena Mimmi; Nicola Perrotti; Rita Citraro; Giorgio Sesti; Andrew Constanti; Giovambattista De Sarro
Journal:  Brain Behav Immun       Date:  2014-07-03       Impact factor: 7.217

6.  Glial contribution to glutamate uptake at Schaffer collateral-commissural synapses in the hippocampus.

Authors:  D E Bergles; C E Jahr
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

7.  NFAT5-dependent expression of AQP4 in astrocytes.

Authors:  Min-Hee Yi; Young Sook Lee; Joon Won Kang; Soo Jin Kim; Sang-Ha Oh; Yong Min Kim; Young Ho Lee; Sang Do Lee; Dong Woon Kim
Journal:  Cell Mol Neurobiol       Date:  2012-11-20       Impact factor: 5.046

8.  Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice.

Authors:  Panpan Xian; Yue Hei; Rui Wang; Tian Wang; Junle Yang; Jianying Li; Zhengli Di; Zhiqin Liu; Andrius Baskys; Weiping Liu; Shengxi Wu; Qianfa Long
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

9.  LncRNA ILF3-AS1 mediated the occurrence of epilepsy through suppressing hippocampal miR-212 expression.

Authors:  Xiaodong Cai; Ling Long; Chao Zeng; Guanzhong Ni; Yangyang Meng; Qiang Guo; Ziyi Chen; Zhong Li
Journal:  Aging (Albany NY)       Date:  2020-05-13       Impact factor: 5.682

Review 10.  Connexins-Based Hemichannels/Channels and Their Relationship with Inflammation, Seizures and Epilepsy.

Authors:  Laura Medina-Ceja; Juan C Salazar-Sánchez; Jorge Ortega-Ibarra; Alberto Morales-Villagrán
Journal:  Int J Mol Sci       Date:  2019-11-27       Impact factor: 5.923

View more
  3 in total

1.  Protective role of muscones on astrocytes under a mechanical-chemical damage model.

Authors:  Rui-Fu Li; Fei Gui; Chao Yu; Yuan-Meng Luo; Liang Guo
Journal:  Ann Transl Med       Date:  2022-09

Review 2.  The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation.

Authors:  Chiara Siniscalchi; Armando Di Palo; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

3.  Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.

Authors:  Shou-Lun Lee; Jing-Ya Hsu; Ting-Chun Chen; Chun-Chih Huang; Tzong-Yuan Wu; Ting-Yu Chin
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.